GGrantIndex
← Leaderboards

Stephen J. Polyak

University Of Washington

$9,333,019
Attributed
$10,357,728
Total exposure
11
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $973.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,599,622 · 12

By mechanism

R01$6,207,258 · 3
U19$2,306,217 · 2
R21$1,091,852 · 3
R56$729,401 · 2
U41$241,894 · 1
R13$23,000 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Hepatitis C Virus

Research focus

Hepatitis C VirusHepatitis CResponseCellsAntiviral AgentsInterferonsSignal TransductionVirusLeadSignal Transduction PathwayGene ExpressionHepatocyteViralLiver DiseasesLiverSignal PathwayChronicBaseCell LineProteinsClinical TrialsVirus DiseasesPathway InteractionsInflammation

Grant awards (35)

Development of an Oral Pan-Coronavirus Drug Cocktail$672,447
R01 · FY2025 · AI · contact PI
Development of an Oral Pan-Coronavirus Drug Cocktail$674,611
R01 · FY2024 · AI · contact PI
Development of an Oral Pan-Coronavirus Drug Cocktail$702,361
R01 · FY2023 · AI · contact PI
Persistence of HCV-Induced Perturbations of Cellular Pathways Post DAA Cure in Advanced Liver Disease$478,533
R56 · FY2020 · AI · contact PI
Urgent Covid-19 Revision to the Center for High-Throughput Functional Annotation of Natural Products$241,894
U41 · FY2020 · AT
Mechanisms of Silymarin Hepatoprotection$438,615
R01 · FY2015 · AT · contact PI
Integrated Network of Cellular Signatures to Natural Products$227,250
R01 · FY2015 · AT · contact PI
Mechanisms of Silymarin Hepatoprotection$438,615
R01 · FY2014 · AT · contact PI
Chemokines and Acute Hepatitis C$225,217
U19 · FY2014 · AI · contact PI
Mechanisms of Silymarin Hepatoprotection$438,614
R01 · FY2013 · AT · contact PI
Chemokines and Acute Hepatitis C$197,045
U19 · FY2013 · AI · contact PI
Effects of Silymarin on the Metabolome$155,897
R01 · FY2013 · AT · contact PI
Mechanisms of Silymarin Hepatoprotection$552,791
R01 · FY2012 · AT · contact PI
Chemokines and Acute Hepatitis C$227,724
U19 · FY2012 · AI · contact PI
Natural Phenotypic Diversity of HCV NS3/4A Protease$193,125
R21 · FY2012 · AI · contact PI
Mechanisms of Silymarin Hepatoprotection$470,250
R01 · FY2011 · AT · contact PI
HCV-Host Interactions During Antiviral Therapy$250,868
R56 · FY2011 · AI · contact PI
Chemokines and Acute Hepatitis C$224,447
U19 · FY2011 · AI · contact PI
HCV Symposium 2011$23,000
R13 · FY2011 · DK · contact PI
Chemokines and Acute Hepatitis C$234,843
U19 · FY2010 · AI · contact PI
HCV-Host Interaction during Acute Hepatitis C$243,480
U19 · FY2009 · AI · contact PI
Mechanisms of Action of Silymarin for Hepatitis C$196,242
R21 · FY2009 · AT · contact PI
Mechanisms of Action of Silymarin for Hepatitis C$247,685
R21 · FY2008 · AT · contact PI
HCV-Host Interaction during Acute Hepatitis C$243,476
U19 · FY2008 · AI · contact PI
Hepatitis C Virus Induced IL-8 & Inhibition of Interferon$266,573
R01 · FY2007 · DK · contact PI
HCV-Host Interaction during Acute Hepatitis C$241,873
U19 · FY2007 · AI · contact PI
Hepatitis C Virus Induced IL-8 & Inhibition of Interferon$274,535
R01 · FY2006 · DK · contact PI
HCV-Host Interaction during Acute Hepatitis C$235,543
U19 · FY2006 · AI · contact PI
Hepatitis C Virus Induced IL-8 &Inhibition of Interferon$281,142
R01 · FY2005 · DK
HCV-Host Interaction during Acute Hepatitis C$232,569
U19 · FY2005 · AI
Hepatitis C Virus Induced IL-8 &Inhibition of Interferon$282,690
R01 · FY2004 · DK
Hepatitis C Virus Proteins and Ethanol$151,600
R21 · FY2004 · AA
Hepatitis C Virus Induced IL-8 &Inhibition of Interferon$330,867
R01 · FY2003 · DK
Hepatitis C Virus Proteins and Ethanol$151,600
R21 · FY2003 · AA
Hepatitis C Virus Proteins and Ethanol$151,600
R21 · FY2002 · AA